<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:linked-data-default="http://data-service.theglobalfund.org/api" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <iati-identifier>47045-IND-T-CHRI</iati-identifier>
  <reporting-org ref="47045" secondary-reporter="0" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Joint Effort for Elimination of Tuberculosis (JEET) for patients seeking care in private sector</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">India - Tuberculosis - Centre for Health Research and Innovation - CHRI.  This program has the following goals: To achieve a rapid decining burden of TB morbidity and mortality while working towards elimination of TB in India by 2025. The objectives of this program are: Systematically engage the private provides  with an increase in case notification to 2 million cases annually.  Improving treatment adherence and treatment support byadoption of iCT tools and partnerships</narrative>
  </description>
  <participating-org role="3" type="15">
   <narrative xml:lang="EN">CCM India</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">CCM India</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="EN">Centre for Health Research and Innovation</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">Centre for Health Research and Innovation</narrative>
  </participating-org>
  <participating-org ref="47045" role="1" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </participating-org>
  <other-identifier ref="96e7d0b5-aa45-4972-81a4-20d6ffcffc23" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <other-identifier ref="IND-T-CHRI" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2017-09-25" type="1"></activity-date>
  <activity-date iso-date="2017-09-25" type="2"></activity-date>
  <activity-date iso-date="2021-03-31" type="3"></activity-date>
  <activity-date iso-date="2021-03-31" type="4"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="4">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Richard CUNLIFFE</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>richard.cunliffe@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="3">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Richard CUNLIFFE</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>richard.cunliffe@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="IN" percentage="100">
   <narrative xml:lang="EN">India</narrative>
  </recipient-country>
  <sector code="12263" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Tuberculosis</narrative>
  </sector>
  <country-budget-items vocabulary="4">
   <budget-item code="C7B597A0-B5A0-4104-8A99-BA94F1C26180" percentage="19.3" vocabulary="4">
    <description>
     <narrative xml:lang="EN">External Professional services (EPS)</narrative>
    </description>
   </budget-item>
   <budget-item code="AEEC85E4-0556-495F-8F31-584DD9FF4EF3" percentage="53.07" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Human Resources (HR)</narrative>
    </description>
   </budget-item>
   <budget-item code="400CEE75-C251-4A85-AA43-BD93DF71A408" percentage="6.65" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Indirect and Overhead Costs</narrative>
    </description>
   </budget-item>
   <budget-item code="2C35AA6C-5E80-4406-B78F-58398CFB1668" percentage="3.13" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Living support to client/ target population (LSCTP)</narrative>
    </description>
   </budget-item>
   <budget-item code="8FF157DA-C279-44D8-8148-6161B33C9E92" percentage="0.77" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Non-health equipment (NHP)</narrative>
    </description>
   </budget-item>
   <budget-item code="F4B643AF-C501-4424-B4BD-74AA0DA9F006" percentage="17.08" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Travel related costs (TRC)</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2018-01-01"></period-start>
   <period-end iso-date="2018-03-31"></period-end>
   <value currency="USD" value-date="2018-01-01">15811</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2018-04-01"></period-start>
   <period-end iso-date="2018-06-30"></period-end>
   <value currency="USD" value-date="2018-01-01">595578</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2018-07-01"></period-start>
   <period-end iso-date="2018-09-30"></period-end>
   <value currency="USD" value-date="2018-01-01">2021165</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2018-10-01"></period-start>
   <period-end iso-date="2018-12-31"></period-end>
   <value currency="USD" value-date="2018-01-01">2352116</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-03-31"></period-end>
   <value currency="USD" value-date="2018-01-01">1542889</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2019-04-01"></period-start>
   <period-end iso-date="2019-06-30"></period-end>
   <value currency="USD" value-date="2018-01-01">1132572</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2019-07-01"></period-start>
   <period-end iso-date="2019-09-30"></period-end>
   <value currency="USD" value-date="2018-01-01">1145970</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2019-10-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2018-01-01">1129047</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-03-31"></period-end>
   <value currency="USD" value-date="2018-01-01">1123886</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-04-01"></period-start>
   <period-end iso-date="2020-06-30"></period-end>
   <value currency="USD" value-date="2018-01-01">1136486</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-07-01"></period-start>
   <period-end iso-date="2020-09-30"></period-end>
   <value currency="USD" value-date="2018-01-01">1146963</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-10-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2018-01-01">1130040</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-03-31"></period-end>
   <value currency="USD" value-date="2018-01-01">1124073</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="8ebe8e3d-0372-43f2-9acf-edba78578e76">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2018-02-15"></transaction-date>
   <value currency="USD" value-date="2018-02-15">7922851.07</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IND-T-CHRI.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centre for Health Research and Innovation</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="ce9068a0-1dad-41bd-ab34-99cf28123500">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-09-06"></transaction-date>
   <value currency="USD" value-date="2019-09-06">-2565832.23</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IND-T-CHRI.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centre for Health Research and Innovation</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="9b00baf5-6d19-4914-9494-dbb564c83729">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-09-06"></transaction-date>
   <value currency="USD" value-date="2019-09-06">5155961.33</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IND-T-CHRI.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centre for Health Research and Innovation</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="5c5a5b5a-7ba2-4b1a-91c9-85fc2a2d1448">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-08-31"></transaction-date>
   <value currency="USD" value-date="2020-08-31">-1854262.33</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IND-T-CHRI.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centre for Health Research and Innovation</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="c4f2a803-03ab-4e72-822c-f16519c8ef8b">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-08-31"></transaction-date>
   <value currency="USD" value-date="2020-08-31">5106028.24</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IND-T-CHRI.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centre for Health Research and Innovation</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="70791801-3401-4b8e-b0a5-1042a03cb08c">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-02-22"></transaction-date>
   <value currency="USD" value-date="2018-02-22">1348730.84</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-CHRI.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centre for Health Research and Innovation</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="c4a412a0-9b20-4b61-949e-b81c8615dfff">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-07-27"></transaction-date>
   <value currency="USD" value-date="2018-07-27">776056</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-CHRI.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centre for Health Research and Innovation</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="15368280-2490-4d19-89fa-17a144d7c316">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-11-02"></transaction-date>
   <value currency="USD" value-date="2018-11-02">1064380</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-CHRI.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centre for Health Research and Innovation</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="0c4a3bf2-7b92-45cc-8894-afe1ff1fa4c2">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-02-07"></transaction-date>
   <value currency="USD" value-date="2019-02-07">579022</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-CHRI.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centre for Health Research and Innovation</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="0a16ad57-eaa6-41f6-9bb2-01be7c4e701e">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-05-07"></transaction-date>
   <value currency="USD" value-date="2019-05-07">865119</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-CHRI.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centre for Health Research and Innovation</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="af03d974-141b-44cd-bc07-fccf329de0ac">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-08-09"></transaction-date>
   <value currency="USD" value-date="2019-08-09">723711</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-CHRI.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centre for Health Research and Innovation</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="041788bd-5240-4093-8afe-942daa34ace6">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-10"></transaction-date>
   <value currency="USD" value-date="2019-09-10">248701</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-CHRI.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centre for Health Research and Innovation</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="e01e6983-9363-4d92-a220-9a6531ba93d6">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-08"></transaction-date>
   <value currency="USD" value-date="2019-11-08">1496628</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-CHRI.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centre for Health Research and Innovation</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="a676815a-b9f5-4969-9956-e6d0fb02bf1b">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-27"></transaction-date>
   <value currency="USD" value-date="2020-02-27">690473</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-CHRI.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centre for Health Research and Innovation</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="be477715-1d53-4641-9394-7bce73cb750d">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-05-13"></transaction-date>
   <value currency="USD" value-date="2020-05-13">865897</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-CHRI.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centre for Health Research and Innovation</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="b9305dd9-d55d-4afe-9203-0270b9253c86">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-09"></transaction-date>
   <value currency="USD" value-date="2020-09-09">1128225</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-CHRI.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centre for Health Research and Innovation</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="15a39e88-bf0a-44d3-946a-58d1197f0e3d">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-11"></transaction-date>
   <value currency="USD" value-date="2020-11-11">1774989</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-CHRI.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centre for Health Research and Innovation</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="76031100-13f2-46c0-8ebf-04cee41a9aa0">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-12"></transaction-date>
   <value currency="USD" value-date="2021-03-12">554438</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-CHRI.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centre for Health Research and Innovation</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <result aggregation-status="0" type="3">
   <title>
    <narrative xml:lang="EN">Impact indicator for IND-T-CHRI</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB cases with RR-TB and/or MDR-TB</narrative>
    </title>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Text: 2.84%</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-10-01"></period-start>
     <period-end iso-date="2020-03-31"></period-end>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 87 Denominator: 3065 Percentage: 2.84</narrative>
       <narrative xml:lang="EN">Target for: 2016</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2019-04-01"></period-start>
     <period-end iso-date="2019-09-30"></period-end>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 2.84 Denominator: 100 Percentage: 2.84</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB incidence rate per 100,000 population</narrative>
    </title>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Text: 217</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-01-01"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 142</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB mortality rate per 100,000 population</narrative>
    </title>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Text: 32</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-10-01"></period-start>
     <period-end iso-date="2020-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 30</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 32</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-01-01"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 15</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-10-01"></period-start>
     <period-end iso-date="2021-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 24</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="EN">Outcome indicator for IND-T-CHRI</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
    </title>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Text: 127.2</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-10-01"></period-start>
     <period-end iso-date="2020-03-31"></period-end>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 159.34</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2018-10-01"></period-start>
     <period-end iso-date="2019-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 179</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2019-10-01"></period-start>
     <period-end iso-date="2020-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 197</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-10-01"></period-start>
     <period-end iso-date="2021-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 209</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Notification of RR-TB and/or MDR-TB cases &#x2013; Percentage of notified cases of bacteriologically confirmed, drug resistant RR-TB and/or MDR-TB as a proportion of all estimated RR-TB and/or MDR-TB cases</narrative>
    </title>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Text: 36%</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-10-01"></period-start>
     <period-end iso-date="2020-03-31"></period-end>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 58347 Denominator: 130000 Percentage: 44.88</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2018-10-01"></period-start>
     <period-end iso-date="2019-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 59400 Denominator: 130000 Percentage: 45.69</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2019-10-01"></period-start>
     <period-end iso-date="2020-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 71078 Denominator: 130000 Percentage: 54.68</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-10-01"></period-start>
     <period-end iso-date="2021-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 82800 Denominator: 130000 Percentage: 63.69</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated</narrative>
    </title>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Text: 46%</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-10-01"></period-start>
     <period-end iso-date="2020-03-31"></period-end>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 15934.56 Denominator: 33197 Percentage: 48.00</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2018-10-01"></period-start>
     <period-end iso-date="2019-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 15687 Denominator: 32682 Percentage: 48.00</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2019-10-01"></period-start>
     <period-end iso-date="2020-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 60590 Denominator: 108196 Percentage: 56.00</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-10-01"></period-start>
     <period-end iso-date="2021-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 48511 Denominator: 74632 Percentage: 65.00</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB treatment coverage: Percentage of new and relapse cases that were notified and treated among the estimated number of incident TB cases in the same year (all form of TB - bacteriologically confirmed plus clinically diagnosed)</narrative>
    </title>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Text: 59%</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-10-01"></period-start>
     <period-end iso-date="2020-03-31"></period-end>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 1994000 Denominator: 2690000 Percentage: 74.13</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2018-10-01"></period-start>
     <period-end iso-date="2019-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 2400000 Denominator: 3131884 Percentage: 76.63</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2019-10-01"></period-start>
     <period-end iso-date="2020-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 2680000 Denominator: 3085600 Percentage: 86.86</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-10-01"></period-start>
     <period-end iso-date="2021-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 2880000 Denominator: 3040000 Percentage: 94.74</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
